Filing metadata

Accession number
0001357550-26-000033
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Sep 28, 2026
Reporting period
Sep 23, 2026
Description
Insider transaction

Explore SEC Filings Hub